title: Terlipressin in chronic hyperdynamic endotoxic shock: is it safe?
authors.forename: Pierre
authors.initials: P
authors.lastname: Asfar
mesh_terms: D000818:Animals; D002908:Chronic Disease; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D006439:Hemodynamics / Q000187:drug effects; D008236:Lypressin / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D010101:Oxygen Consumption / Q000187:drug effects; D012449:Safety; D012772:Shock, Septic / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D000077585:Terlipressin; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*
chemical_list: D014662:Vasoconstrictor Agents; D008236:Lypressin; D000077585:Terlipressin